| 1 |
35599097 | Corrigendum to "Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1" [Canc. Lett. 385 (2017) 65-74]. | 2022 Aug 1 |
1 |
| 2 |
30536599 | Simvastatin and the Rho-kinase inhibitor Y-27632 prevent myofibroblast transformation in Peyronie's disease-derived fibroblasts via inhibition of YAP/TAZ nuclear translocation. | 2019 Apr |
2 |
| 3 |
31934265 | Simvastatin Mitigates Apoptosis and Transforming Growth Factor-Beta Upregulation in Stretch-Induced Endothelial Cells. | 2019 |
2 |
| 4 |
30220377 | Simvastatin reduces TGF-β1-induced SMAD2/3-dependent human ventricular fibroblasts differentiation: Role of protein phosphatase activation. | 2018 Nov 1 |
6 |
| 5 |
27840243 | Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-β1/Gfi-1 axis. | 2017 Jan 28 |
4 |
| 6 |
26574150 | Statin pretreatment inhibits the lipopolysaccharide-induced epithelial-mesenchymal transition via the downregulation of toll-like receptor 4 and nuclear factor-κB in human biliary epithelial cells. | 2016 Jun |
3 |
| 7 |
27123120 | Simvastatin blocks TGF-β1-induced epithelial-mesenchymal transition in human prostate cancer cells. | 2016 May |
5 |
| 8 |
30024693 | [Different effects of simvastatin on keloid fibroblasts under hypoxia and TGF-β1 treatment]. | 2016 Mar |
2 |
| 9 |
26559850 | Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration. | 2015 Dec |
1 |
| 10 |
24471776 | Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts. | 2014 Jan-Feb |
4 |
| 11 |
24506800 | Low intravitreal angiopoietin-2 and VEGF levels in vitrectomized diabetic patients with simvastatin treatment. | 2014 Nov |
1 |
| 12 |
23817018 | Simvastatin attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells. | 2013 |
3 |
| 13 |
24098525 | Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis. | 2013 |
1 |
| 14 |
22127053 | Simvastatin inhibits sphingosylphosphorylcholine-induced differentiation of human mesenchymal stem cells into smooth muscle cells. | 2012 Feb 29 |
2 |
| 15 |
22331026 | Statins induce the accumulation of regulatory T cells in atherosclerotic plaque. | 2012 May 9 |
1 |
| 16 |
22391067 | Effect of simvastatin on transforming growth factor beta-1-induced myofibroblast differentiation and collagen production in nasal polyp-derived fibroblasts. | 2012 Jan-Feb |
5 |
| 17 |
20463291 | The mevalonate cascade as a target to suppress extracellular matrix synthesis by human airway smooth muscle. | 2011 Mar |
2 |
| 18 |
21864337 | Simvastatin inhibits TGFβ1-induced fibronectin in human airway fibroblasts. | 2011 Aug 24 |
4 |
| 19 |
21968503 | Modulators of induction of plasminogen activator inhibitor type-1 in HepG2 cells by transforming growth factor-β. | 2011 Nov |
1 |
| 20 |
19023089 | Efficacy of simvastatin treatment of valvular interstitial cells varies with the extracellular environment. | 2009 Feb |
2 |
| 21 |
19358180 | Simvastatin impairs smad-3 phosphorylation and modulates transforming growth factor beta1-mediated activation of intestinal fibroblasts. | 2009 May |
3 |
| 22 |
18203812 | Simvastatin attenuates release of neutrophilic and remodeling factors from primary bronchial epithelial cells derived from stable lung transplant recipients. | 2008 Mar |
2 |
| 23 |
15677772 | Simvastatin inhibits growth factor expression and modulates profibrogenic markers in lung fibroblasts. | 2005 Apr |
1 |
| 24 |
16045013 | [Effect of simvastatin on cardiac fibrosis in patients with essential hypertension]. | 2005 Jun |
1 |
| 25 |
15298857 | Connective tissue growth factor expression and induction by transforming growth factor-beta is abrogated by simvastatin via a Rho signaling mechanism. | 2004 Dec |
3 |
| 26 |
10500210 | 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors up-regulate transforming growth factor-beta signaling in cultured heart cells via inhibition of geranylgeranylation of RhoA GTPase. | 1999 Sep 28 |
2 |